Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.44 · Revenue $605.24M · 6 analysts
Est. EPS $0.29 · Revenue $571.96M · 5 analysts
Est. EPS $1.65 · Revenue $2.35B · 5 analysts
Est. EPS $0.45 · Revenue $606.69M · 3 analysts
$0.25 per share
$0.25 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $2.2B | +13.9% | +6.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $166.4M | -0.1% | +29.3% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +28.3% | +2.0% | +5.9% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +15.4% | -3.7% | +13.1% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +7.7% | -12.2% | +21.6% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $197.1M | -6.3% | +1103.8% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +9.1% | -17.7% | +1031.3% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 534.6% | -24.5% | -10.1% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.14x | -20.2% | +9.3% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $3.0B | +20.5% | +4.2% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 1.30 vs 1.32 | -1.6% | 0.50 vs 0.44 | +14.4% |
| Revenue Surprise | $2.2B vs $2.2B | +0.3% | $606.0M vs $605.2M | +0.1% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | ORTENZIO ROBERT A | director | Common Stock | D | 770,000 | $34.65 |
| Aug 21, 2026 | ORTENZIO ROBERT A | director | Common Stock | D | 770,000 | $34.65 |
| Aug 21, 2026 | ORTENZIO ROBERT A | director | Common Stock | D | 150,000 | $34.65 |
| Aug 21, 2026 | ORTENZIO ROBERT A | director | Common Stock | D | 20,000 | $34.65 |
| Aug 21, 2026 | ORTENZIO ROBERT A | director | Common Stock | D | 30,000 | $35.65 |
Operator: Good morning and thank you for joining us today for Concentra Group Holdings Parent, Inc. Earnings Conference Call to discuss the second quarter 2026 results. Speaking today are the company's Chief Executive Officer, Keith Newton; and the company's President and Chief Financial Officer, Matt DeCanio. Management will give you an overview and then open the call for questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to Concentra's plans, expectations, strategies, intentions and beliefs. You are hereby cautioned that these forward-looking statements may be affected by the important factors, among others, set forth in Concentra's earnings release and in reports that are filed or furnished to the SEC. Consequently, actual operations and results may differ materially from those discussed in the forward-looking statements. These forward-looking statements are based on the information available to management of Concentra today, and the company assumes no obligation to update these statements as circumstances change. At this time, I will turn the conference call over to Mr. Keith Newton. William Newton: Good morning, and thank you for joining us today. Before we comment on our second quarter results, I would like to share my perspective on the announcement that was made yesterday afternoon in our press release. After more than a decade as Concentra's Chief Executive Officer and a relationship with a company that has spanned over 30 years, I have decided effective November 1 of this year to transition from the CEO role into a new role at Concentra as its Executive Chairman of the Board. At that time, Matt Dicanio, our President and Chief Financial Officer, will become Concentra's President and Chief Executive Officer. Bob Ortenzio, our current Chairman, will continue to serve on our Board as a Director. Many thanks to Bob for his leadership and guidance over the last 11 years, especially over the last couple of years as a public company. Leading this organization and its more than 13,000 colleagues has been the privilege of my career. I cannot be prouder of what we have accomplished together at Concentra. Today, we stand as the clear leader in occupational health, powered by a best-in-class team that remains focused every day on our mission of improving the health of America's workforce. The company has experienced tremendous growth, particularly over the last decade, driven by the dedication and execution of our teams. Together, we have reached significant milestones throughout our journey, including the successful completion of our IPO in 2024. This transition is the result of a multi-year succession plan that we have worked on with our Board of Directors, and there is no …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
William Keith Newton | Chief Executive Officer & Director | USD 3,043,513 | Male | 1963 | Active |
Matthew T. DiCanio | President & Chief Financial Officer | USD 1,783,074 | Male | 1983 | Active |
Giovanni Gallara | Executive Vice President & Chief Clinical Services Officer | USD 1,375,366 | Male | 1975 | Active |
Michael A. Kosuth | Executive Vice President & Chief Operating Officer of East | USD 1,361,823 | Male | 1958 | Active |
Su Zan Nelson | Executive Vice President & Chief Accounting Officer | USD 1,324,933 | Female | 1964 | Active |
John A. deLorimier | Executive Vice President and Chief Information & Technology Officer | USD 1,153,284 | Male | 1960 | Active |
Timothy F. Ryan | Executive Vice President & Chief Legal Counsel | USD 1,150,986 | Male | 1961 | Active |
John R. Anderson FACOEM | Executive Vice President & Chief Medical Officer | USD 1,150,764 | — | 1950 | Active |
Bill Chapman | Vice President of Strategy & Investor Relations | — | Male | — | Active |
Danielle Kendall | Executive Vice President & Chief People Officer | — | Female | 1969 | Active |
Thomas A. Devasia | Executive Vice President and Chief Marketing & Innovation Officer | — | Male | 1970 | Active |
Concentra (CON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bank of New York Mellon Corp lessened its holdings in shares of Concentra Group Holdings Parent, Inc. (NYSE: CON) by 2.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 911,753 shares of the company's stock after selling
Here is how Concentra Group (CON) and Cytokinetics (CYTK) have performed compared to their sector so far this year.
DALLAS & BOISE, Idaho--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational and workforce health services, today announced the opening of its first Idaho medical center, expanding access to workforce health solutions for employers and employees throughout the Boise region. The new medical center is in Federal Way Plaza at 3237 South Federal Way, Boise, Idaho 83705, providing convenient access for employers and employees throughout the city and the surrounding Treasure Va.
NEW YORK, July 16, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 88.75 cents a share on its common stock, payable September 15, 2026 to stockholders of record as of August 19, 2026. Consolidated Edison, Inc. is a holding company that provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc. (CECONY), a regulated utility providing electric service in New York City and New York's Westchester County, gas service in Manhattan, the Bronx, parts of Queens and parts of Westchester, and steam service in Manhattan; Orange and Rockland Utilities, Inc. (O&R), a regulated utility serving customers in a 1,300-square-mile area in southeastern New York State and northern New Jersey; and Con Edison Transmission, Inc., a regulated company primarily under the oversight of the Federal Energy Regulatory Commission, that develops and invests in electric transmission projects and owns interests in both electric and gas assets.
